Mixed.
PISA is definitely a bad. Revenues there has halved, so it's become a real sink. It's really negligible now.
They're nearly free cashflow positive for the year, which is a huge turn around in 2H. So at least the business appears sustainable going forward and dilution from a heavily discounted capital raise should be now off the table.
The green shoot is probably the Solutions business which grew revenues up 21% half-on-half. Probably mostly driven by the Cambridge and Oxford deals.
Hopefully they can continue this traction into the next financial year and demonstrate some better top line growth.
Mixed. PISA is definitely a bad. Revenues there has halved, so...
Add JAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.005(1.89%) |
Mkt cap ! $69.74M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 27.0¢ | 25.5¢ | $15.04K | 58.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 74330 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 3410 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
27.0¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 26.0¢ | 27.0¢ | 25.5¢ | 65552 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| JAN (ASX) Chart |
